|Title||Cardiovascular disease risk scores in identifying future frailty: the Whitehall II prospective cohort study.|
|Publication Type||Journal Article|
|Year of Publication||2013|
|Authors||Bouillon, K, Batty, GD, Hamer, M, Sabia, S, Shipley, MJ, Britton, A, Singh-Manoux, A, Kivimäki, M|
|Date Published||2013 May|
|Keywords||Aged, Algorithms, Cardiac Rehabilitation, Cardiovascular Diseases, Disability Evaluation, Female, Follow-Up Studies, Frail Elderly, Humans, London, Male, Middle Aged, Morbidity, Motor Activity, Prognosis, Prospective Studies, Quality of Life, Risk Assessment, Risk Factors|
OBJECTIVES: To examine the capacity of existing cardiovascular disease (CVD) risk algorithms widely used in primary care, to predict frailty.
DESIGN: Prospective cohort study. Risk algorithms at baseline (1997-1999) were the Framingham CVD, coronary heart disease and stroke risk scores, and the Systematic Coronary Risk Evaluation.
SETTING: Civil Service departments in London, UK.
PARTICIPANTS: 3895 participants (73% men) aged 45-69 years and free of CVD at baseline.
MAIN OUTCOME MEASURE: Status of frailty at the end of follow-up (2007-2009), based on the following indicators: self-reported exhaustion, low physical activity, slow walking speed, low grip strength and weight loss.
RESULTS: At the end of the follow-up, 2.8% (n=108) of the sample was classified as frail. All four CVD risk scores were associated with future risk of developing frailty, with ORs per one SD increment in the score ranging from 1.35 (95% CI 1.21 to 1.51) for the Framingham stroke score to 1.42 (1.23 to 1.62) for the Framingham CVD score. These associations remained after excluding incident CVD cases. For comparison, the corresponding ORs for the risk scores and incident cardiovascular events varied between 1.36 (1.15 to 1.61) and 1.64 (1.50 to 1.80) depending on the risk algorithm.
CONCLUSIONS: The use of CVD risk scores in clinical practice may also have utility for frailty prediction.
|PubMed Central ID||PMC3632981|
|Grant List|| / / British Heart Foundation / United Kingdom |
RG/13/2/30098 / / British Heart Foundation / United Kingdom
R01 HL036310 / HL / NHLBI NIH HHS / United States
/ / Medical Research Council / United Kingdom
R01 AG034454 / AG / NIA NIH HHS / United States
R01 AG013196 / AG / NIA NIH HHS / United States
PG/11/63/29011 / / British Heart Foundation / United Kingdom
R01AG034454 / AG / NIA NIH HHS / United States
R01HL036310 / HL / NHLBI NIH HHS / United States
/ / Wellcome Trust / United Kingdom
R01AG013196 / AG / NIA NIH HHS / United States